COVID-19-Related Guidance Documents for Industry, FDA Staff, and Other Stakeholders | FDA

COVID-19-Related Guidance Documents for Industry, FDA Staff, and Other Stakeholders | FDA

Information for industry The FDA is committed to providing timely recommendations, regulatory information, guidance, and technical assistance necessary to support rapid COVID-19 response efforts. FDA has issued more than 50 COVID-19-related guidances to date.

In case you missed it FDA Insight podcast: The opioid epidemic and COVID-19 Dr. Anand Shah, FDA’s Deputy Commissioner for Medical and Scientific Affairs, welcomes Megan Moncur, Associate Director of Opioid Policy, to the show to discuss the opioid epidemic and how it has been impacted by the COVID-19 pandemic.